Bare Sky Marketing Healthcare Content Writing Services

Health System Marketing For The New Normal - John G. Baresky

As the nation progresses through the pandemic and the new normal is established, growing healthcare systems are sharpening a more competitive edge

Preparation For Successful 2021 Healthcare Social Media Marketing Campaigns - John G. Baresky

Social media is a key element of many healthcare marketing campaigns and it's important to learn how to realign brand, digital, product and service marketing strategies to account for the new opportunities and challenges in 2021

Healthcare Digital Marketing Retargeting Strategy For 2021 - John G. Baresky

2021 represents a year of new business challenges for the healthcare industry. Retargeting is a form of online advertising that orchestrates follow-up opportunities to engage viewers that have visited and left a website or social media venue.

Healthcare Email Marketing: Start With The Basics - John G. Baresky

The basic elements of successful healthcare email marketing campaigns

Healthcare Providers Investing In Website User Satisfaction - John G. Baresky

7 priorities to improve healthcare website patient experience and profitability. Medical groups, hospitals, health systems and specialty practices are improving how they manage their website and digital strategy to achieve their clinical care and commercial business objectives.

Revitalizing Healthcare Keyword And Content Marketing SEO Strategy - John G. Baresky

Always changing, healthcare clinical and commercial terminology demands a simplistic keyword SEO content strategy

Healthcare Marketers Monitoring Social Media Audience Shifts - John G. Baresky

Healthcare marketers are viligently monitoring social media audience changes and preparing for 2021

Landing Pages To Engage Healthcare Professionals - John G. Baresky

Nurses, doctors and other clinicians are unique personas. Marketing to them and their leadership is challenging. Giving more thought to your landing pages has never been more important.

Reaching Medical Professionals With Google Ads: Timing Is Everything - John G. Baresky

How To More Effectively Engage Healthcare Professionals With PPC

COVID-19 Creates A New Normal In Healthcare Marketing Strategy - John G. Baresky

Digital marketing strategies spanning website, remote conferencing. PPC, email marketing, mobile and other elements take on new importance.

Healthcare Email Marketing Best Practices - John G. Baresky

Successful healthcare email marketing follows its own set of rules!

5 Options: Improve Health Literacy In Clinical, Business, Consumer Storytelling - John G. Baresky

Living in the digital age means we all benefit from creating and sharing information; it's even more important that we can readily understand it according to our level of health literacy...

Revisiting Digital Resources To Recapture Market Share And Sales - John G. Baresky

Resourceful healthcare marketing teams are retracing steps to find and deploy under-utilized digital assets

10 Ways To Improve Your Healthcare Business Writing - John G. Baresky

10 elements improve your business writing and your credibility while magnifying the learning experience for your healthcare business readers

7 Drivers: Pharmaceutical Television Advertising - John G. Baresky

Direct-to-consumer TV ads deliver results for prescription drug and other healthcare product manufacturers Television advertising for prescription drugs is a controversial practice but is an important component of the marketing strategy for many pharmaceutical manufacturers plus other healthcare product manufacturers.

Improving Super Bowl TV Advertising Effectiveness - John G. Baresky

Healthcare television advertisers can improve ROI by embracing audience second-screening / two-screening habits

Healthcare Digital Marketing 90-Day Strategy and Tactics - John G. Baresky

For many healthcare, medical device and pharmaceutical product manufacturers and service providers, the 4th quarter is underway and the end of the fiscal year is approaching. Every minute and every dollar counts more than ever.

6 Options To Improve Healthcare Content Marketing Performance -John G. Baresky

Sometimes even the best healthcare content can't be found... Quality healthcare content requires significant time, financial and technical investment to develop. Even with solid expertise and considerable resources, the highest quality material can be seemingly ineffective as search engines and audiences stream by it.

Practical Innovation For Healthcare Digital Marketing: 5 Options - John G. Baresky

Healthcare digital marketing initiatives need to stay ahead of the pace as patient care, technology and competitor innovation never stagnate. Even when digital assets are performing at peak levels and sales are robust, there is already room for improvement.

A Deceptively Unique And Effective Healthcare Broadcast And Digital Marketing Strategy - John G....

For healthcare industry and other marketers, it is an optimum model to revisit and compare against existing TV advertising and digital marketing activities to develop more impactful and measurable marketing initiatives with greater ROI. With dwindling broadcast television audiences and an ever-increasing selection of alternative digital and social media venues for audiences to migrate to, healthcare marketers need to develop better advertising / marketing strategies and reap more...

8 Actions To Improve Healthcare Email Marketing Strategy And Tactics - John G. Baresky

The top email providers are Gmail, Yahoo, Outlook, GMX, Zoho, iCloud, AOL, Elude according to MUO... While numerous digital communication and promotion options exist, email continues to be one of the most preferred channels. Despite the demise of email marketing forecast years ago, it continues to be an attractive and effective tool in engaging audiences. Its performance and utility intrigues marketers and at the same time challenges them and their audience based on sheer volume and...

Healthcare Brand And Digital Marketing Organizational Effectiveness: Put Five Ducks In A Row -...

Organize, Strategize, Optimize To Increase Effectiveness And Sales... Digital marketing initiatives are a mainstay in healthcare industry commercial organizations and sales generation activities. On the surface, they are aesthetically engaging and smoothly functional. Underneath, there is a wide array of organizational, financial and technical resources paddling furiously to develop and deploy them.

Five Winning Healthcare Content Marketing Practices - John G. Baresky

The most successful healthcare content marketing strategies embrace the concept of relentlessly jockeying for position when it comes to audience engagement, search ranking and ROI... Healthcare And Technology Compete Against Themselves Everyday... Healthcare content marketing is a never ending race. Healthcare and digital technology are two industries which literally outpace themselves with innovation; as quickly as existing customer / sales opportunities are accounted for, new ones evolve...

Mobilizing Your Mobile Healthcare Marketing Strategy - John G. Baresky

Mobilize Healthcare Marketing And Sales ROI... With much of the globe accessing the Internet for information from mobile devices, mobile marketing is a critical element to consider in effectively engaging customers and driving sales. Clinicians (nurses, doctors, pharmacists, researchers, KOLs, etc.), healthcare administrators, risk management, purchasing professionals, patients and consumers rely on mobile devices to readily access information.

Healthcare Digital Marketing ROI: Boost It with Infographs - John G. Baresky

Social media and other digital channels offer an array of choices to engage consumer, patient, clinician, payer and other stakeholders. There are many resources and strategies to choose from. Infographs have powerful attributes making strategic assets to improve healthcare digital marketing performance, social sharing, brand awareness and ROI. Go the distance in making it easy to share; there are countless infographs and other content featured in blogs and websites not easily shared or...

Healthcare Digital Marketing / Social Media Marketing Course Correction Strategies- John G. Baresky

Healthcare digital marketing and social media marketing strategies are complex and inherently challenging to effectively manage. They require close alignment of significant staff, financial and technical resources to achieve maximum ROI. Upon reaching prime level of performance, the new challenge is maintaining productive results, breaking through plateaus and cultivating further growth.

A Simulation: The Buyer's Journey Of A Digital Healthcare Consumer And Social Media - John G....

Experience The Buyer’s Journey Of The Digital Healthcare Consumer… — A Combination Of Multiple Digital Venues, Social Media, Key Influencers And Personal Needs Making health plan choices is an annual buyer’s journey for many. It used to be as simple as “signing up for the company plan”. Changing trends in benefit designs (HSAs, HMOs, PPOs, FSAs, ACOs, health system-based plans, etc.) combined with consumer-driven healthcare and healthcare reform cultivated more variation. Digital resources...

Ten Healthcare Digital Marketing Actions To Improve ROI - John G. Baresky

Consumers, patients, clinicians, payers and other stakeholders across the healthcare industry coexist in a digital ocean of information sharing and data generation. Healthcare marketers of products and services live here as well and seek to maintain existing connections with customers and make new ones as more digital marketing options and venues emerge. Customer preferences, new digital technology and advancements in healthcare have a shared inertia healthcare marketers have to furiously...

Pinterest and Healthcare Marketing -A Strategy Discussion - John G. Baresky

Like Amazon, Pinterest Delivers.... It seems every company is trying to find a way to "Amazon" their sales initiatives to reach more customers, promote product, establish social media presence and provide immediate access to generate a sale. What do so many healthcare companies and their marketers overlook in their digital and social media strategies?

Abbott Amplifies Market Access For BinaxNOW COVID-19 Rapid Antigen Test - John G. Baresky

Abbott Laboratories (NYSE: ABT) has announced it is opening access to its BinaxNOW Covid-19 rapid antigen test

Court Decision Impacts UnitedHealth Group's Behavioral Healthcare Business Unit - John G. Baresky

UnitedHealth Group weighs decision impacting its mental health and substance abuse business unit

Walmart Partners With PBM Innovator Capital Rx - John G. Baresky

Capital Rx’s precision pricing strategy based on accuracy and technology attracts Walmart’s attention

CENTENE ANNOUNCES ACQUISITION OF NEXTLEVEL HEALTH PARTNERS - John G. Baresky

Centene (NYSE: CNC) continues to strategically expand with its purchase of Illinois-based NextLevel Health Partners. The deal will enable Centene to add over 54,000 Medicaid members to its ranks.

AstraZeneca Fortifies Global Market Access Strategy With COVID-19 Vaccine - John G. Baresky

AstraZeneca's COVID-19 Vaccine Development Initiative Is Enhancing Its Global Pharmaceutical Market Access Strategy

Biosimilars Finding Their Way In U.S. And Global Markets - John G. Baresky

2019 was a record year of FDA biosimilar approvals in the United States but that doesn't mean the savings they represent will be that much easier to come by

UnitedHealth Group Launches Major Medicare Advantage Expansion - John G. Baresky

UnitedHealth Group goes on the offensive in the growing but financially and competitively challenging Medicare Advantage healthcare sector

A Profile of Indian Health Service - IHS - John G. Baresky

Indian Health Services (IHS) is the federal agency providing healthcare to American Indians (AI) and Alaska Natives (AN). IHS administers mental, physical, social and spiritual health programs and services for members of recognized tribes.

Six Pillars Of Healthcare Market Access Strategy In Emerging Markets - John G. Baresky

The global healthcare marketplace continues to evolve. Pharmaceutical manufacturers, medical device manufacturers and healthcare service companies are driving forward to find and develop the promising opportunities that exist in emerging markets.

Haven Health - Amazon, Berkshire Hathaway JPMorgan Chase Partnership Seeks New CEO - John G. Baresky

The healthcare partnership of Amazon, Berkshire Hathaway and JPMorgan Chase is seeking a new CEO. Haven’s present CEO, Dr. Atul Gawande, will continue as a senior leader of the Haven organization in the role of chairperson of its board of directors.

Vyepti: Lundbeck's New Migraine Therapy - John G. Baresky

The new migraine drug Vyepti (eptinezumab-jjm) from Lundbeck (OTCMKTS: HLUYY) competes in a thickly competitive therapeutic sector where managed care contracting and market access strategy with MCOs and PBMs will be critical for it to be successful..

Centene-WellCare Divesting Medicaid Plans In Two States To Anthem - John G. Baresky

Anthem will buy Medicaid operations owned by WellCare Health Plans in Missouri and Nebraska as Centene offloads specific units to win approval of its WellCare acquisition by regulators.

4 Walgreens Partnership Profiles: Kroger, McKesson, Microsoft, Prime Therapeutics - John G. Baresky

Walgreens Boots Alliance ( NASDAQ: WBA ) ranks at number 17 on the Fortune 500 list of largest firms. Kroger, McKesson, Microsoft and Prime Therapeutics are four of Walgreens' present strategic partners.

IngenioRx: Anthem, CVS Health Join Forces - John G. Baresky

IngenioRx - Healthcare Business Climate Changer... The recent announcement of a PBM partnership between Anthem and CVS Healthcare is a significant development. Anthem is one of the largest managed care organizations in the United States. CVS Health is a coast-to-coast healthcare conglomerate comprised of retail / mail order / specialty pharmacy, home infusion, PBM and other clinical, commercial healthcare units.

Express Scripts Next Move ... Amazon?...Walmart? - John G. Baresky

With Anthem leaving in 2019 and a new year coming up fast, what can Express Scripts do for itself and investors? Anthem says, "Goodbye"... The pharmacy benefit management (PBM), health insurance, Blue Cross Blue Shield and investment communities are awash in chatter and speculation upon hearing the news Anthem does not plan to be a client of Express Scripts effective 2019.

California Pricing Regulations Drive Costs Higher - John G. Baresky

California, Other States Going Grizzly On Pharmaceutical Manufacturers ...According to the U.S. Census Bureau, California is the most populous state; with 39.25 million people its boundaries contain more individuals than the 21 least populous states combined... On Monday 10/9, California Governor Jerry Brown signed into law legislation requiring pharmaceutical manufacturers to report certain price hikes for prescription medicines.

CENTENE CORPORATION: BUCKING THE TREND - John G. Baresky

Over $40 billion in annual sales... Centene is a unique managed care conglomerate based in St. Louis, Missouri which has quietly grown into an industry leader. Founded in 1984, Centene has over 30,000 employees and generates over $40 billion in annual sales.

Outcomes-Based Pharmaceutical Manufacturer Contracts With Health Plans Getting Traction - John G.

Pharmaceutical manufacturers getting access via outcomes contracting... Health plans are increasingly seeking to feature performance guarantees in their contracts with pharmaceutical manufacturers. As drug costs rise, insurers want more bottom line certainty plan members have positive outcomes based on the therapeutic efficacy of the prescription medications they are taking.

The Mechanics of Deductibles, Big Data and Healthcare Marketing - John G. Baresky

Deductibles turn gears in consumer choice, plan design and risk management... Deductibles have become a standard healthcare benefit feature in many plans. In basic terms, a deductible is a specific dollar amount a health insurance plan requires a member to pay out-of-pocket towards medical care costs each year before the member's plan begins to pay for covered expenses.

Amgen’s Lumakras (sotorasib) Earns FDA Oncology Approval - John G. Baresky

FDA approves Amgen's Lumakras (sotorasib) as a uniquely novel oncology treatment

FDA Approves New Women's Healthcare Oncology Drug Jemperli (dostarlimab-gxly) - John G. Baresky

Jemperli (dostarlimab-gxly) is FDA approved to treat recurrent or advanced dMMR endometrial cancer

Abecma (idecabtagene vicleucel) Earns FDA Oncology Approval - John G. Baresky

Bristol Myers Squibb and bluebird bio launch Abecma, a CAR-T therapy for multiple myeloma

ADC Therapeutics' Zynlonta (loncastuximab tesirine-lpyl) Earns FDA Oncology Approval - John G....

FDA Issues Zynlonta (loncastuximab tesirine-lpyl) Accelerated Approval For Oncology

G1 Therapeutics' Cosela (trilaciclib) Earns FDA Approval For Oncology Care - John G. Baresky

The U.S. Food and Drug Administration (FDA) has approved a new oncology therapy developed by G1 Therapeutics. Cosela (trilaciclib) earned an indication from the FDA to decrease the incidence of chemotherapy-induced myelosuppression in adult patients when administered before a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer ( ES-SCLC).

Takeda Buys Maverick Therapeutics - Expands Oncology Pipeline - John G. Baresky

Takeda acquires oncology innovator Maverick Therapeutics

Merck and Sanofi Form Oncology Collaboration - John G. Baresky

Merck and Sanofi explore the development of an oncology tandem therapy

Y-mAbs Therapeutics Earns FDA Oncology Approval For Danyelza (naxitamab-gqgk) - John G. Baresky

Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) has earned FDA approval for Danyelza (naxitamab-gqgk), in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), for pediatric patients one year of age and older and adult patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a partial response, minor response, or stable disease to prior therapy.

October Is Natonal Breast Cancer Awareness Month - John G. Baresky

Breast Cancer Is A Significant Global Healthcare Challenge October is National Breast Cancer Month, a national observance in the United States that began in 1985. About 1 out of every 8 women in the U.S. (approximately 12%) will be diagnosed with breast cancer in their lifetime.

A New Identity: Seattle Genetics Is Now Seagen - John G. Baresky

Seattle Genetics Corporate Rebrand To Seagen Mirrors Its Transformation To A Global BioPharma Leader In Oncology

ILLUMINA ACQUIRING ONCOLOGY DIAGNOSTICS INNOVATOR GRAIL FOR $7.1 BILLION - John G. Baresky

Gene sequencing leader Illumina Inc. (NASDAQ: ILMN) is investing $7.1 billion in cash and stock to buy oncology diagnostics brain trust Grail Inc. in a pairing of two west coast life sciences companies. Based in San Diego, California, Illumina is a leader in the development, manufacturing and marketing of integrated systems for analysis of genetic and biological testing.

Astex Pharmaceuticals Inqovi Earns Oncology FDA Approval - John G. Baresky

Astex Pharmaceuticals, a division of Otsuka (OTCMKTS: OTSKY) has received FDA approval for Inqovi (decitabine and cedazuridine). It is indicated for the treatment of myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) in adult patient populations.

Genentech Breast Cancer Therapy Phesgo Earns FDA Approval - John G. Baresky

The FDA has approved Phesgo (pertuzumab, trastuzumab and hyaluronidase–zzxf) to treat adult patients with HER2-positive breast cancer that has spread to other parts of the body and for treatment of adult patients with early HER2-positive breast cancer.

LILLY SCORES ONCOLOGY TRIFECTA WITH RETEVMO FDA APPROVAL - John G. Baresky

Eli Lilly's (NYSE: LLY) Retevmo (selpercatinib) has earned FDA approval. Retevmo’s 3 FDA-approved uses provide oncologists with a triple-threat to treat more patients. Its oral formulation is a plus to avoid costly and cumbersome IV administration and the two capsule strengths provide flexibility in dosing for clinicians.

ABBVIE'S TWO NEW ONCOLOGY PARTNERSHIPS - John G. Baresky

John G. Baresky AbbVie (NYSE: ABBV) is wasting no time in making the most out of 2020. Following the FDA approval of their breakthrough Women's Health uterine fibroid therapy Oriahann ((elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules)) and completion of their $63 billion acquisition of Allergan, AbbVie has immediately followed through by signing deals with Genmab (NASDAQ: GMAB) and Jacobio Pharmaceuticals.

LYNPARZA (olaparib) GAINS NEW PROSTATE CANCER INDICATION - John G. Baresky

The FDA has issued approval for Lynparza (olaparib) in the treatment of adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with Xtandi (enzalutamide by Pfizer/Astellas) or Zytiga (abiraterone by Centocor/Johnson & Johnson).

Lung Cancer Therapy Zepzelca (lurbinectedin) Earns FDA Approval - John G. Baresky

The FDA has approved Zepzelca (PM1183) for the treatment of adult patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based chemotherapy.

SARCLISA: SANOFI'S NEW ONCOLOGY DRUG EARNS FDA APPROVAL - John G. Baresky

A new multiple myeloma therapy... Sarclisa (isatuximab-irfc) is a new IV oncology product from Sanofi that is approved by the FDA for use in the treatment of adult patients with relapsed refractory multiple myeloma who have already received at least two prior therapies.

Koselugo Gives Neurologists And Oncologists A New Option To Treat Pediatric Neurofibromatosis...

AstraZeneca and Merck Collaboration Earns FDA New Drug Approval: Koselugo (selumetinib)

New Breast Cancer Drug Tukysa (tucatinib) By Seattle Genetics Earns FDA Approval - John G. Baresky

Tukysa (tucatinib) Is A Tyrosine Kinase Inhibitor (TKI) of HER2 Indicated For The Treatment Of Breast Cancer

Immunomedics' Trodelvy (sacituzumab govitecan-hziy) Earns FDA Oncology Approval - John G. Baresky

New oncology therapy Trodelvy (sacituzumab govitecan-hziy) has an indication for adult patients with metastatic triple-negative breast cancer who received at least two prior therapies for metastatic disease

Padcev and Keytruda Receive FDA Oncology Breakthrough Designation - John G. Baresky

Padcev (enfortumab vedotin-ejf) a first-in-class antibody-drug conjugate (ADC) and Keytruda (pembrolizumab) a monoclonal antibody (mAb) therapy have been issued FDA Breakthrough Designation for bladder oncology treatment

Merck Keytruda and Eisai Lenvima Achieve Triple Approval - John G. Baresky

Oncology initiatives in Women's Healthcare have gained another valuable therapy to improve patient care and outcomes... Merck & Co.'s Keytruda and combination partner therapy Eisai's Lenvima will keep their respective marketing and sales units very busy in the upcoming months.

LILLY'S CYRAMZA (ramucirumab) GAINS 6th FDA-APPROVED ONCOLOGY INDICATION - John G. Baresky

The U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), in combination with erlotinib for first-line treatment of patients with metastatic non-small cell lung cancer ( NSCLC) with epidermal growth factor receptor ( EGFR) exon 19 deletions or exon 21 (L858R) mutations.

Opdivo (nivolumab) and Yervoy (ipilimumab) Earn 4th Oncology FDA Indication - John G. Baresky

Bristol Myers Squibb continues its success in oncology by earning a liver cancer indication from the FDA for its Opdiva and Yervoy mAB tandem

Amazon Web Services Unveils Strategic Healthcare Accelerator Program - John G. Baresky

AWS partners with KidsX and Children's Hospital Los Angeles to launch a healthcare innovation accelerator program

Amazon Launches National Telehealth And In-Person Care Program For Employees Plus Other Companies...

Amazon Care expands its healthcare service for Amazon workers nationwide and is marketing them to other employers

Amazon Is A Founding Partner In The Moving Health Home Coalition - John G. Baresky

Amazon, Ascension, Intermountain Healthcare join forces with 4 other healthcare enterprises to drive changes in home care for patients

AMAZON UNVEILS "CARE HUB" A NEW ALEXA HEALTHCARE SERVICE - John G. Baresky

Amazon is launching a new Alexa-based healthcare service called "Care Hub". It was created to help individuals care for aging family members that live apart from them.

AMAZON ENTERS WEARABLES MARKET WITH "HALO" - John G. Baresky

Amazon is taking the plunge into the wearables market sector with the introduction of "Halo". It will be competing with Apple Watch, Garmin, Google Fitbit and other contenders in the fitness tracker and wearable healthcare consumer technology categories.

Amazon and Anthem BCBS Launch Alexa and Echo Healthcare Benefits Applications - John G. Baresky

The nation’s largest Blue Cross Blue Shield affiliate, Anthem (NYSE: ANTM), has announced it is expanding the member support services it offers by launching a new program based on Amazon's (NASDAQ: AMZN) Alexa and Echo applications.

Amazon Launches New Pharmacy Program And Delivery Services Nationwide - John G. Baresky

Amazon escalates growth and expectations of its pharmacy enterprise

Amazon COVID-19 Feeding Frenzy - John G. Baresky

Is Amazon's COVID-19 Healthcare Coalition membership the catalyst it needs to succeed in rural healthcare, hospitals and health systems?

Amazon and Sharecare Grow Alexa's Healthcare Smarts - John G. Baresky

Amazon has chosen to partner with healthcare information and technology innovator Sharecare to accelerate and improve the performances of its Alexa platform used in healthcare settings.

Amazon Launches Employee Medical Care Program Expansion - John G. Baresky

Amazon taking on a larger role in employee health by providing access to primary care for more of its associates through a contract with Crossover Health medical group

What Is PillPack's Next Move? - John G. Baresky

In 2020 Amazon and PillPack have 2 new PBMs partnerships underway, learn more about their clinical and commercial strategy here...

Amazon Treks Deeper Into Healthcare: Amazon Care - John G. Baresky

Amazon Care Amazon ( NASDAQ: AMZN ) has launched an employee health clinic in Seattle for corporate staff named "Amazon Care". It was introduced via website, "Amazon.Care", a venue presently accessible to outside audiences but not formally announced to the public or investors.

Amazon Launches Transcribe Medical - John G. Baresky

Amazon introduces transformational healthcare automatic speech recognition ( ASR ) application which accurately processes patient and clinician conversation plus medical and pharmacological descriptions or terminology to enrich EHR / EMR data resources

Amazon Expands Healthcare Enterprise With Acquisition Of Health Navigator - John G.Baresky

Amazon has purchased a healthcare technology startup known as "Health Navigator". Health Navigator, based in Chicago, Illinois, is a clinical healthcare technology firm founded by an emergency medicine physician, Dr. David Thompson.

Amazon And PillPack Have Options - John G. Baresky

Amazon and its online pharmacy unit, PillPack, have a significant challenge. On the surface, it appears to involve only a small, Iowa-based healthcare and prescription data technology company, ReMyHealth, but drastically scales up and potentially involves some of the largest retail and mail order pharmacy, MCO / PBMs and pharmacy associations in the nation - and a somewhat ambiguous organization known as Surescripts.

Amazon Web Services Team Up With Pittsburgh Health Data Alliance - John G. Baresky

In a new healthcare quest, Amazon Web Services ( AWS ) unit partners with University of Pittsburgh, University of Pittsburgh Medical Center and Carnegie Mellon University Amazon is extending its reach into healthcare. Their cloud computing business unit, AWS Cloud will share its machine learning ( artificial intelligence technology ) and enormous cloud computing resources with the Pittsburgh Health Data Alliance ( PHDA ).

Amazon's New Online Mail Order Pharmacy "PillPack" Is Underway! - John G. Baresky

Amazon has demonstrated its ability to enter new markets and successfully disrupt them. Numerous retailer and other commercial sectors have felt their squeeze; even the logistics companies transporting products to consumers and businesses feel the competitive pressure.

Amazon Web Services ( AWS / Cloud ) In Talks With Healthcare Data Giant Cerner John G. Baresky

Based on insights from management consulting leader PwC; "Amazon does have expertise that makes it a natural candidate to look for ideas that would reform the U.S. health care industry as it tries to control costs"... It is no secret Amazon has been diligently expanding its presence in the healthcare sector.

Amazon: Who Will They Bite In Healthcare? -John G. Baresky

South America's largest predator, the Amazon's Black Caiman alligator can grow up to 20 feet in length and over 1,000 pounds... Healthcare distributors, medical suppliers, wholesalers, GPOs, retailers and even product manufacturers are at risk... As Amazon prepares to explore the healthcare sector for more revenue and customers, there are numerous strategies and competitive maneuvers for it to consider.

Amazon: Preparing To Flood The Healthcare Industry -John G. Baresky

Amazon's current flows year round... It's the holiday season and shoppers are in the stores and online. Amazon is taking orders, filling orders, shipping orders. Once the season is over, they capably process returns, refunds and exchanges -all the while shipping out new orders. Amazon's is relentlessly moving forward.

Intellia Therapeutics Success In Gene Therapy Leaps Ahead - John G. Baresky

Intellia Therapeutics (NASDAQ: NTLA) and its partner Regeneron are on to something big in genetic sciences and anticipation is building for future breakthroughs.

CVS Health Launches Clinical Trial Services - John G. Baresky

CVS Health expands business model with new Clinical Trial Services unit

Biogen's Alzheimer's Drug Aduhelm Earns FDA Approval - John G. Baresky

The FDA has approved Biogen's (NASDAQ: BIIB) Aduhelm (aducanumab) for the treatment of Alzheimer's disease, giving patients and medical professionals a desperately needed treatment option of which there are very few. Biogen developed the drug in collaboration with Tokyo, Japan-based Eisai, Co. (OTCMKTS: ESALY).

AXA Chooses Microsoft As Telehealth Partner - John G. Baresky

Paris-based financial services and insurance giant AXA (OTCMKTS: AXAHY) has selected enterprise technology leader Microsoft (NASDAQ: MSFT) as its partner to build a full-strength telehealth program for its clients and their members. AXA is one of the largest health insurers in the world.

Pfizer Launches Phase 1 Clinical Trial For Oral COVID-19 Antiviral Drug - John G. Baresky

Global pharmaceutical giant Pfizer (NYSE: PFE) is evaluating antiviral product pipeline candidates to treat COVID-19: PF-07321332 and PF-07304814

FDA Approves Regeneron's Evkeeza (evinacumab-dgnb) Cholesterol-Lowering Therapy - John G. Baresky

The U.S. Food and Drug Administration (FDA) has issued Regeneron approval for its advanced cholesterol-reducing therapy Evkeeza (evinacumab-dgnb). The product is approved and indicated as an adjunct therapy to other low-density lipoprotein cholesterol (LDL-C) lowering drugs for use with treating patients diagnosed with homozygous familial hypercholesterolemia (HoFH).

New Lupus Drug Lupkynis (voclosporin) by Aurinia Pharmaceuticals Approved By FDA - John G. Baresky

Lupkynis (voclosporin) is a new therapeutic option to treat Lupus Nephritis (LN)

ViiV Healthcare Unveils New HIV Therapy Cabenuva - John G. Baresky

ViiV Healthcare, a company exclusively devoted to the HIV/AIDs marketplace, has announced the FDA has approved its latest new therapy Cabenuva (cabotegravir and rilpivirine)

Merck Introduces New Cardiovascular Drug Verquvo (vericiquat) - John G. Baresky

FDA approves Verquvo (vericiguat), a new cardiovascular and heart drug co-developed by Merck and Bayer AG

UROVANT'S NEW OAB DRUG GEMTESA (vibegron) Earns FDA APPROVAL - John G. Baresky

The U.S. Food and Drug Administration (FDA) has approved Urovant Sciences' new drug Gemtesa (vibegron) for the treatment of overactive bladder ( OAB) with symptoms of urge urinary incontinence ( UUI), urgency and urinary frequency in adults.

WALGREENS AND DOORDASH ESTABLISH DELIVERY SERVICE PARTNERSHIP - John G. Baresky

Walgreens (NASDAQ: WBA) has signed on DoorDash as a second consumer home delivery service partner in addition to Postmates

Orladeyo (berotralstat) by BioCryst Pharmaceuticals Earns FDA Approval - John G. Baresky

The U.S. Food and Drug Administration (FDA) has issued BioCryst Pharmaceuticals approval for its new drug, Orladeyo (berotralstat), with an indication to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.

Rhythm Pharmaceuticals' Imcivree (setmelanotide) Earns FDA Approval - John G. Baresky

Imcivree (setmalonotide) is indicated for patients diagnosed with obesity due to POMC, PCSK1 or LEPR genetic deficiencies

FDA Approves Lucira Health's COVID-19 All-In-One Test Kit - John G. Baresky

The U.S. Food and Drug Administration (FDA) has issued emergency use authorization for Lucira Health’s COVID-19 All-In-One Test Kit

Amgen, Takeda, UCB Launch Multiple Worldwide COVID-19 Clinical Trials - John G. Baresky

Amgen, Inc. (NASDAQ: AMGN), Takeda Pharmaceuticals, Inc. (NYSE: TAK) and UCB SA (EBR: UCB) have initiated worldwide clinical trials through the COVID R&D Alliance.

Zokinvy (lonafarnib) Earns FDA Approval - John G. Baresky

FDA approves Zokinvy (lonafarnib) based on an indication to reduce the risk of death due to Hutchinson-Gilford progeria syndrome and for the treatment of certain processing-deficient progeroid laminopathies

2020: A Robust Year For Contract Research Organizations (CROs) - John G. Baresky

Contract research organizations have been around for decades. They have been the go-to for pharmaceutical, medical device and other companies seeking immediate access to specialized research resources, quality control monitoring and other services. Their role in the healthcare industry and the array of capabilities they possess has multiplied many times over.

Regeneron's COVID-19 Monoclonal Antibody Tandem Earns FDA Emergency Use Authorization - John G....

FDA issues Regeneron's novel monoclonal antibody REGEN-COV2 emergency use authorization to treat COVID-19

Eli Lilly's Bamlanivimab Issued FDA Emergency Use Authorization To Treat COVID-19 - John G. Baresky

FDA issues emergency use authorization (EUA) for Eli Lilly's investigational monoclonal antibody therapy (mAb) bamlanivimab for the treatment of mild-to-moderate COVID-19 in adult and pediatric patients

Regeneron's Inmazeb Earns FDA Approval For Ebola Virus Treatment - John G. Baresky

Regeneron's Inmazeb, a monoclonal antibody trifecta, takes on the Ebola virus

Veklury Is The First FDA-Approved Treatment For COVID-19 - John G. Baresky

Veklury (remdesivir) Approved By The FDA

Roche And Atea Pharmaceuticals: $350 Million COVID-19 Oral Antiviral Exclusive Licensing Deal -...

Roche and Atea Pharmaceuticals join forces to accelerate the development of an oral antiviral COVID-19 drug

CUE HEALTH RECEIVES $481 MILLION IN FUNDING FROM HHS - John G. Baresky

Cue Health COVID-19 diagnostic test produces accurate results in 20 minutes and does no require laboratory resources.

REGENERON SEEKING EARLY USE AUTHORIZATION FOR COVID-19 ANTIBODY THERAPY - John G. Baresky

Regeneron (NASDAQ: REGN) is excited about the promising clinical trial research results it is achieving with its COVID-19 antibody treatment candidate REGN-COV2. They are having conversations with the U.S. Food and Drug Administration (FDA) about receiving Emergency Use Authorization (EUA) clearance for REGN-COV2 to accelerate the product's availability to the marketplace.

ABBVIE'S NEW WOMEN'S HEALTHCARE PRODUCT ORIAHNN EARNS FDA APPROVAL - John G. Baresky

Oriahnn is a first-in-class pharmaceutical therapy regimen indicated for the management of heavy menstrual bleeding associated with uterine fibroids; it was developed through a collaboration between AbbVie and Neurocrine Biosciences

Eli Lilly Alzheimer's Diagnostics Agent Earns FDA Approval - John G. Baresky

Avid Radiopharmaceuticals, a business unit of Eli Lilly (NYSE: LLY ), has received FDA approval for its Tauvid (flortaucipir F18) therapy used in the imaging of a distinctive brain characteristic associated with Alzheimer’s disease referred to as tau pathology.

MERCK UNVEILS TRIPLE THREAT COVID-19 STRATEGY - John G. Baresky

Kenilworth, New Jersey-based Merck (NYSE: MRK) has launched a 3-prong business initiative to combat COVID-19 and once again demonstrate its clinical and competitive mettle in global healthcare. Their strategy is centered on spearheading the development of two vaccines and one antiviral agent.

AMIVAS EARNS FDA APPROVAL FOR MALARIA DRUG ARTESUNATE - John G. Baresky

The FDA has approved Artesunate for injection as an antimalarial therapy indicated for the initial treatment of severe malaria in adult and pediatric patients.

Regulated Medical Waste Risk, Cost and Opportunity: COVID-19 - John G. Baresky

Medical waste companies are pivotally important in the quest to overcome the global challenge of COVID-19

Pulmotect Spurs Development Of COVID-19 Treatment Candidate PUL-042 - John G. Baresky

Texas-based Pulmotect Gets FDA Greenlight For Phase II Clinical Trial of PUL-042 - A Nebulizer Administered Inhaled Therapeutic Agent To Treat COVID-19 Patients

Gilead Sciences' Epclusa Scores Pediatric Hep C Win - John G. Baresky

Supplemental application to treat hepatitis C approved by FDA... Epclusa (sofosbuvir and velpatasvir), in combination with ribavirin, has been issued a supplemental approval to be used in children ages 6 years and older or weighing at least 37 pounds (17 kilograms) diagnosed with any of the six Hepatitis C virus (HCV) genotypes - or strains - without cirrhosis (liver disease) or with mild cirrhosis.

WALGREENS ROLLING OUT DELIVERY IN 15 MAJOR U.S. CITIES - John G. Baresky

For over 100 Walgreens has built its esteemed pharmacy empire on strategic innovation. As it rolls into a new decade, it has already introduced a new chief medical officer, Dr. Kevin Ban, a new president, Richard Ashworth, and is now expanding delivery service from 2 metropolitan areas into an additional 13.

Roche Escalating COVID-19 Test Production - John G. Baresky

Roche has communicated its diagnostics business unit is accelerating the production of its Elecsys Anti-SARS-CoV-2 antibody test to come to the aid of U.S. and world markets. The company has shared the news that the U.S. Food and Drug Administration (FDA) has issued it an Emergency Use Authorization (EUA) for the diagnostic product.

Multiple Sclerosis Drug Zeposia (ozanimod) Earns FDA Approval - John G. Baresky

New Multiple Sclerosis Drug Zeposia (ozanimod) FDA Approval Adds To Bristol Myers Squibb's Success In 2020

FDA Seeks Input On Conducting Type 2 Diabetes Clinical Safety Trials - John G. Baresky

FDA Revising 2008 Type 2 Diabetes Industry Guidance

Baxter Receives Good News From FDA About Peri-Strips - John G. Baresky

The FDA has issued 510(k) clearance for Baxter's new generation of Peri-Strips Dry with Veritas collagen matrix (PSDV) staple-line reinforcement material products that feature peel-and-secure technology.

Horizon Therapeutics Introduces Tepezza (teprotumumab-trbw) - John G. Baresky

Horizon Therapeutics (NASDAQ: HZNP) has received approval for its thyroid eye disease Tepezza (teprotumumab-trbw) pharmaceutical product. Thyroid eye disease (TED) is a healthcare condition centered on inflammation of the eyes, eye muscles, eyelids, tear glands and fatty tissues behind the eye. TED, also known as Graves' Orbitopathy or Ophthalmopathy, is an autoimmune condition.

Nexletol: FDA Approves Esperion Therapeutics Cholesterol Lowering Agent - John G. Baresky

Nexletol is an add-on cholesterol lowering treatment for use with patients prescribed statins

FDA E-Cigarette And Vaping Enforcement Action Ramps Up - John G. Baresky

FDA Issues Direct Warnings And Takes Further Action Against Retailers and Manufacturers Of Unauthorized E-Cigarette Products

15 Facts About Johnson & Johnson: A Global Healthcare Leader - John G. Baresky

15 Important Facts About Johnson & Johnson

EVALI: “E-Cigarette, Or Vaping, Product Use Associated Lung Injury” - John G. Baresky

CDC has defined vaping-related illnesses as “EVALI” –an abbreviation for “e-cigarette, or vaping, product use associated lung injury”. As the issues surrounding the use and healthcare consequences of e-cigarettes and vaping continue, medical professionals, the Centers for Disease Control and the FDA are dialing in quickly while engaging multiple related concerns.

Novo Nordisk Launches New Oral Therapy For Diabetes Care Patients "RYBELSUS" - John G. Baresky

With diabetes as a growing healthcare issue around the globe, medical professionals benefit from having more advanced treatment options to prescribe their patients... With the FDA's approval, Novo Nordisk has announced they are launching a new oral therapy for diabetes care. Expectations are the new product named "Rybelsus" will generate over $5 billion in sales by 2026.

BIOSIMILAR CLASH OF THE TITANS: - John G. Baresky

Biosimilar Warfare... Merck & Co and partner Samsung Bioepis have introduced their biosimilar version of Johnson & Johnson's Remicade in the United States healthcare marketplace. They are not shy in their intent to make a name in the biosimilar sector for themselves.

Blue Cross Blue Shield Report Indicates Diabetes Is A Widening Healthcare Issue With Millennials...

A recently released BCBS report focused on diabetes care further defines the reach and associated issues of diabetes; its results were especially concerning as it confirms a higher prevalence of the disease in a younger population segment... Blue Cross Blue Shield Health Index...

U.S. Healthcare Business Models: A Tradition Of Change Since 1751 -John G. Baresky

United HealthCare continues the trend... Take a close look at the picture. It is the first hospital in the United States. Known as "Pennsylvania Hospital", it was founded on May 11, 1751 by Benjamin Franklin and Dr. Thomas Bond. It is located in Philadelphia, Pennsylvania and is on the National Register of Historic Places.

Catalysts Driving Healthcare Industry Change 2018

Digitalization, Consolidation, Private Equity, Business Model Hybridization, Audience Migration, Amazon, Google, Apple 2018 promises to be an eventful year across multiple healthcare sectors based on 2017's high performance direction. While healthcare has never been an industry to hover from year to year, there will be an array of significant changes impacting clinician, commercial and consumer / patient interests.

Microsoft and Teladoc Health Joins Forces In Hospitals and Health Systems - John G. Baresky

Microsoft (NASDAQ: MSFT) and Teladoc Health (NYSE: TDOC) are collaborating on a new initiative that targets the hospital and healthcare system vertical. Microsoft plans to integrate Teladoc Health’s Solo platform into its Microsoft Teams program.

Telehealth's Next Growth Phase Rapidly Approaches - John G. Baresky

A positive outlook for telehealth and the nation as it enters the new normal

Truveta: Fourteen Health Systems Form Patient Data Analytics Enterprise - John G. Baresky

Truveta is a new organization founded by hospitals and health systems focused on discovering and applying healthcare data insights to optimize patient outcomes

Veterans Administration (VA) and Apple Telehealth Initiative - John G. Baresky

The U.S. Department of Veterans Affairs (VA) and Apple are partnering to provide better care for veterans nationwide. The two organizations have launched a telehealth program centered around the distribution and use of iPads.

Planning And Executing Your 2021 Telehealth Strategy - John G. Baresky

Healthcare provider organizations are developing flexible and profitable telehealth strategies for 2021

NightWare Gains FDA Approval For Use With Apple Watch And Apple iPhone - John G. Baresky

NightWare, Inc. develops Apple Watch and Apple iPhone solution to help patients with sleep disorders triggered by PTSD

Microsoft Cloud For Healthcare: 15 Days To Launch - John G. Baresky

The company has announced its new Microsoft Cloud dedicated to healthcare will be available on 10/30/20. Microsoft introduced the development of this new initiative in May and is now positioned to benefit an array of eager medical professionals, healthcare provider organizations, partners and investors.

Apple Introduces New Blood Oxygen Reading Series 6 Watch And Fitness+ Workout Subscription...

Series 6 Apple Watch reads blood oxygen levels and Fitness+ workout videos will feature new editions weekly

Virtual Health Assistants: Improving Patient Care and Medical Professional Productivity - John G....

Virtual Health Assistants Embraced by Patients, Medical Professionals and Healthcare Provider Organizations

Behavioral Health: New Teletherapy Firms Challenging Traditional Office-Based Counseling

Traditional In-Person Counseling And Virtual Counseling Business Models Competing For Patients And Revenue

UPMC: $1 Billion Life Sciences Investment - John G. Baresky

University of Pittsburgh Medical Center (UPMC) and its Enterprises unit are deploying $1 billion for life sciences investments; UPMC continues to advance patient care as a global healthcare leader

FDA Launches New Digital Health Center of Excellence - John G. Baresky

The FDA has unveiled its new Digital Health Center of Excellence as a major enhancement to its ability to support the use of technology in patient care. The new agency unit will operate within the Center for Devices and Radiological Health (CDRH) located in Silver Spring, Maryland.

UnitedHealth Group Partners With Microsoft - John G. Baresky

UnitedHealth Group (UHG) and Microsoft Corp. are developing and launching a "back-to-workplace" healthcare initiative called ProtectWell. It's a formal plan and technology-driven solution for employers and their staff members.

Introducing The COVID-19 High Performance Computing Consortium - John G. Baresky

IBM Takes Leadership Role With Washington In COVID-19 Supercomputing Initiative

Microsoft's New Healthcare Artificial Intelligence Initiative - John G. Baresky

Artificial Intelligence (AI) is at the center of Microsoft's new AI for Good healthcare program

Patient EHR Access Via Mobile Coming Soon? - John G. Baresky

Proposed changes to the 21st Century Cures Act include making electronic health record (EHR) data and other healthcare information accessible to patients/consumers via mobile technology. Why is Epic Systems against it? Numerous benefits include health literacy and personal patient care knowledge while privacy, security and costs are important considerations.

DNAnexus Investor Gene Pool Includes Google And Microsoft - John G. Baresky

Microsoft and Google are both investors in DNAnexus, a high profile precision medicine start-up... DNAnexus is a leader in biomedical informatics and data management. Its latest round of funding totaled approximately $58 million. DNAnexus, which has developed a cloud-based platform for biomedical informatics and data management, will apply the monies towards precision medicine and genomic data management solutions for clinical trials.

Return Of The House Call: Telemedicine Gaining Ground -John G. Baresky

Telemedicine Here To Stay... Healthcare has always been an industry synonymous with change. How it is paid for, who provides it, procedures performed, medicines prescribed are touchpoints which are top-of-mind when it comes to healthcare industry changes. Telemedicine and how / where healthcare is provided is increasingly becoming a mainstay topic.

HPV Disease And Immunization Awareness: An Essential Of The New Normal - John G. Baresky

HPV education and prevention will save thousands of lives in the new normal

WALGREENS: POSITIVE MENTAL HEALTH FOR COVID-19 VACCINE RECIPIENT PATIENTS - John G. Baresky

Walgreens (NASDAQ: WBA) has shared the encouraging results of an online survey they conducted designed to model the national outlook of those patients receiving a COVID-19 vaccination

CanSinoBIO Manufacturing 500 Million Single Dose COVID-19 Vaccines Annually - John G. Baresky

CanSino Biologics Commits To Yearly 500 Million Single-Dose COVID-19 Vaccine Production Goal

Johnson & Johnson and Merck Join Forces In COVID-19 Vaccine Production - John G. Baresky

Johnson & Johnson escalating COVID-19 vaccine production with support from Merck and BARDA

China's Sinopharm To Produce 3 Billion Doses Of COVID-19 Vaccines Annually - John G. Baresky

Sinopharm accelerates global market access strategy with new 3 billion dose COVID-19 vaccine annual production quota

FDA Issues Pfizer - BioNTech COVID-19 Vaccine Emergency Use Authorization - John G. Baresky

The FDA has issued emergency use authorization for Pfizer’s (NYSE: PFE) and BioNTech’s (NASDAQ: BNTX) coronavirus vaccine.

Nestle Health Sciences Acquires Aimmune Therapeutics for $2.6 Billion - John G. Baresky

Nestle covets Aimmune's novel Palforzia therapy that is FDA-approved to treat peanut allergies

HHS Contracts With Walgreens And CVS For National COVID-19 Immunization Program- John G. Baresky

CVS Health and Walgreens Chosen By Health and Human Services (HHS) For National Coronavirus Vaccine Program

Ebola Outbreak In Democratic Republic of Congo - John G. Baresky

Ebola persists as a threat in Africa despite widespread vigilance and responsive containment measures

FLU SEASON 2020-2021: A Tandem Flu And COVID-19 Strategy - John G. Baresky

Preparation for the 2020-2021 flu season is underway even as we continue to grapple with the immediate threat of COVID-19. The upcoming flu season will be even more strategically regarded than in years past and the anticipated demand for flu immunizations greater.

New FDA Drug Approval: Palforzia for Children with Peanut Allergies - John G. Baresky

Palforzia (arachis hypogaea) is a new drug approved by the FDA for patients allergic to peanuts.

Moderna and BARDA Sign COVID-19 Vaccine Development Contract - John G. Baresky

Moderna is deploying its mRNA expertise to immunization development... Washington has signed on another biotech firm to help find a vaccine solution to COVID-19. Moderna and the Biomedical Advanced Research and Development Authority ( BARDA) have entered into an agreement to accelerate the development of an immunization for COVID-19.

FDA Approves Audenz For Influenza A Virus H5N1 Subtype - John G. Baresky

Audenz (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted), developed by Seqirus, has been approved by the FDA. The product is indicated for use in persons 6 months of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.

Johnson & Johnson's COVID-19 BARDA Contract: A $1 Billion Collaboration - John G. Baresky

Let's hope other governments and companies step up to the plate with similar or greater commitments to developing COVID-19 solutions

Coronavirus 2019-nCoV: A Public Health Emergency of International Concern (PHEIC) - John G. Baresky

WHO has issued PHEIC status only 5 times before... The World Health Organization has declared the Coronoavirus 2019-nCoV a Public Health Emergency of International Concern ( PHEIC). The declaration of PHEIC is rare. Upon its designation, various government agencies, healthcare institutions and other stakeholders are officially organized to act and escalate measures in collaboration with each other to combat the issue.

Q&A Flu Season Update: 2019-2020 - John G. Baresky

The Centers for Disease Control ( CDC ) plus other government healthcare agencies and medical professionals are closely monitoring what is shaping up to be a formidable Flu season. Who is most at risk for Flu? Individuals spanning infant to elderly are susceptible to the Flu virus.

Merck Develops First Regulatory Approved And Licensed Ebola Vaccine: Ervebo - John G. Baresky

Merck ( NYSE: MRK ) has announced its Ebola vaccine, Ervebo, has been approved by European regulators. The product, which has already been deployed in its investigational format in the Democratic Republic of Congo ( DRC ), was cleared by Europe's "Committee For Medicinal Products for Human Use ( CHMP )" and will be manufactured in Germany.

Measles Threat Persists As U.S. Moves Forward Into Flu Season - John G. Baresky

Clinicians and government health agencies are concerned. Fall is the threshold to the Flu season and the emergence of Measles earlier in the year is a continuing issue.

World Health Organization Partners With Facebook And Instagram To Stop Spread Of Inaccurate...

Public health experts center on false content online as playing a significant role in scaring parents away from getting their children vaccinated... Facebook and Instagram will direct users searching for Measles immunization information and other types of vaccine details to the World Health Organization ( WHO ) for credible facts.

HPV Vaccines: Oncology And STD Medical Breakthroughs -John G. Baresky

Options to immunize against HPV... Gardasil, Gardasil 9 and Cervarix: your table is ready. Each of these products is FDA-approved to prevent HPV infection; Gardasil is a Merck product, Cervarix is produced by GlaxoSmithKline. They are all effective against HPV types 16 and 18, the two high-risk HPVs which cause about 70% of cervical cancers and a greater percentage of some of the other HPV-associated cancers.

International Nurses Day, May 12, 2021 - John G. Baresky

Happy Birthday, Florence Nightingale, Founder Of Modern Nursing

May Is National Asthma Awareness Month - John G. Baresky

The CDC and EPA recognize May as National Asthma Awareness Month

Women's History Month: Doctor Adeline Fagan

Her Leadership And Sacrifice: Dr. Adeline Marie Fagan - Learn her story and follow her example

Pediatric Transplant Week 4/18-4/26: Organ Donors Needed! - John G. Baresky

National Pediatric Transplant Week focuses on saving the lives of those persons just starting out in life. - Organ transplant medical professionals need more persons to register as organ donors so they can save more lives.

Executive Profile: Brian Thompson, New Chief Executive Officer of UnitedHealthcare - John G. Baresky

UHC, the nation's largest health insurer, has a new CEO: Brian Thompson

EXECUTIVE PROFILE: Merck's New CEO Robert Davis - John G. Baresky

Global pharmaceutical giant Merck (NYSE: MRK) has named Robert Davis as their next chief executive officer. Davis joined Merck as a chief financial officer in 2014. .

New Walgreens CEO Roz Brewer Hails From Starbucks - John G. Baresky

An executive profile of Walgreens' new CEO Rosalind Brewer, presently the only black woman Fortune 500 CEO

National Organ Donation Day Is Sunday, February 14th, 2021 - John G. Baresky

National Organ Donation Day Is Sunday, February 14th, 2021 --organ donors save lives; register now to become an organ donor! The Health Resources & Services Administration (HRSA) designates Sunday 2/14/ 21 as National Donor Day. National Donor Day recognizes persons in need of an organ transplant, organ donors and urges more people to register to become organ donors.

Caffeine vs. COVID - Starbucks: Free Coffee For Front-Line Healthcare Workers And First...

Health & wellness and corporate social responsibility continue as key elements in Starbucks' 2020 business strategy

Women Making History In Healthcare: Her Leadership - John G. Baresky

Women are making history and creating the future of healthcare in the United States

NATIONAL NURSES DAY MAY 6 AND NATIONAL NURSES WEEK 5/6-5/12 - John G. Baresky

National Nurses Day was launched on May 6, 1982 by the American Nursing Association (ANA) - National Nurses Week Begins On May 6 And Ends On May 12 -Florence Nightingale's Birthday

200th BIRTHDAY OF FLORENCE NIGHTINGALE: FOUNDER OF MODERN NURSING - John G. Baresky

National Nurses Day on May 6th kicked off National Nurses Week. Its closing day, May 12th, is International Nurses Day that is also dedicated to the founder of modern nursing practice, Florence Nightingale, who was born on May 12th, 1820.

National Donor Day, Friday, February 14, 2020 - Be An Organ Donor! - John G. Baresky

Friday, February 14th is National Donor Day --Donor as in Organ Donation - Over 120,000 persons in the United States are in need of an organ transplant. For many of them, their life depends on it. Almost 40,000 organ transplants were conducted in 2019, setting another record for this medical procedure.

University Of Iowa Pediatric Neurosurgeon Earns Highest National Award - John G. Baresky

Dr. Arnold Menezes, MBBS, University of Iowa professor and vice-chairperson of the Department of Neurosurgery, earns 2019 Franc D. Ingraham Award for Distinguished Service and Achievement. It is the highest honor issued by the American Association of Neurological Surgeons and Congress of Neurological Surgeons Section on Pediatric Neurological Surgery

Bristol Myers Squibb Builds Executive Ranks with Elizabeth Mily - John G. Baresky

Bristol Myers Squibb (BMS) is fortifying its senior leadership with the addition of Elizabeth Mily as Executive Vice President, Strategy & Business Development. According to information shared by BMS (NYSE: BMY), Elizabeth will lead strategy and all business development activities such as strategic partnerships, mergers & acquisitions and other important initiatives.

Walgreens Announces New President - John G. Baresky

Deerfield, Illinois-based Walgreens Boots Alliance (NASDAQ: WBA) has selected John Standley as president of Walgreens. Standley will be responsible for all of the pharmacy giant's store operations in the United States.

Dark Chocolate a Healthier Choice for Valentine's Day - John G. Baresky

February is fast approaching and chocolate is a Valentine's Day staple. Over 55 million pounds of chocolate are sold during the week leading up to Valentine's day. Chocolate is not an essential food group nor an essential vitamin but its popularity deserves attention on any given day.

Walgreens 2020: New Chief Medical Officer - John G. Baresky

Walgreens signs Dr. Kevin Ban, MD, as new Chief Medical Officer

A First In U.S. History: Females Outnumber Males In Medical Schools - John G. Baresky

The Association of American Medical Colleges ( AAMC ) reports that based on its data, more females than males are enrolled as medical students throughout the nation. Medical school applicants and medical school enrollees are transforming the future of physician ranks.

Abbott CEO Miles White Transformed The Global Pharmaceutical, Diagnostic And Medical Device...

The CEO with a 20 year track record of clinical and commercial success is stepping down. A strategic succession of executive leadership at Abbott is underway. After 21 years as CEO, legendary pharmaceutical, diagnostic and medical device merger & acquisition strategist and corporate leader Miles White is handing over the CEO reins of Abbott to his planned successor, Robert Ford, Chief Operating Officer and President of Abbott, Inc.

CEO Resigns As Major Broadcasters Ban JUUL Ads And FDA Probe Begins - John G. Baresky

In an era of wellness, healthcare costs, tobacco avoidance and pharmaceutical medical device regulation; how did e-cigarettes and vaping products avoid more medical scrutiny until now? JUUL CEO resigns... Kevin Burns has resigned as Juul's CEO. Burns will be replaced by former Altria executive K.C. Crosthwaite.

Michigan Health System Mega Merger: Beamont Health and Spectrum Health - John G. Baresky

Proposed Beaumont Health and Spectrum Health mega-merger disrupts Michigan's healthcare marketplace

USDA Invests $42 Million In Rural America For Healthcare And Education - John G. Baresky

The USDA has announced it is funding 86 projects through the Distance Learning and Telemedicine (DLT) grant program. It helps rural healthcare organizations and rural educators improve their connections with and better support their patients or students. The new flow of monies is largely attributed to the demands and issues triggered by the COVID-19 pandemic.

Major Health System Merger: Northwestern Medicine and Palos Health - John G. Baresky

​A leading Chicago area community health system, Palos Health, merges with Northwestern Medicine

Cherokee Nation Opens First Tribal-Associated Medical School In The United States - John G. Baresky

Cherokee Nation advances medical academics and the future of patient care with new medical school

Rural Healthcare And Broadband Access: Will Biden-Harris Keep Their Promise? - John G. Baresky

The Biden-Harris Plan To Build Back Better In Rural America promises $20 billion for rural broadband improvements -they need to honor their commitment

NorthShore University HealthSystem Acquires Northwest Community Healthcare - John G. Baresky

NorthShore University HealthSystem has formally completed its acquisition of Northwest Community Healthcare

Tenet Healthcare's New $1.1 Billion Investment In Surgical Centers - John G. Baresky

Tenet Healthcare Corp. (NYSE: THC) is closing out 2020 with a strategic $1.1 billion acquisition of up to 45 ambulatory surgery centers from SurgCenter Development (SCD).

UPMC And CarePathRx Form Partnership In $400 Million Deal - John G. Baresky

UPMC is selling their home infusion and specialty pharmacy company, Chartwell, to CarePathRx for about $400 million. As part of the deal, it is also committed to being a strategic investor in CarePathRx which is private equity owned.

Washington Takes Action To Help Rural Healthcare - John G. Baresky

The Department of Health and Human Services (HHS) follows through on an executive order issued by President Trump with the introduction of the Rural Action Plan

Rural Health Practitioner of the Year: Dr. Jeffrey Viar - John G. Baresky

North Carolina Physician Earns Prestigious Award from the National Rural Health Association (NRHA). Dr. Jeffrey Viar has been named Rural Health Practioner of the Year.

Encompass Health and The University of Iowa Collaborate To Advance Patient Rehabilitation Care -...

One of the nation’s largest rehabilitation health networks, Encompass Health (NYSE: ECH), and The University of Iowa Health Care Hospital & Clinics have launched a collaboration through the opening of a new facility they will jointly operate. The venture is centered around its new inpatient rehabilitation center, the University of Iowa Health Network Rehabilitation Hospital.

Intermountain Healthcare and Sanford Health Announce Merger Plans - John G. Baresky

Two leading health systems, Intermountain Healthcare and Sanford Health, are joining forces

Celebrate National Rural Health Week 11/15-11/21 - John G. Baresky

The Health Resources & Services Administration (HRSA) has designated 11/15-2/21 National Rural Healthcare Week. It focuses on the leadership, innovation and challenges that rural medical professionals and their healthcare provider organizations embrace everyday to fulfill their care mission. A pivotal day of focus is Thursday, 11/19 which is designated as National Rural Health Day.

NATIONAL UROLOGY MEDICAL GROUP FORMED WITH PRIVATE EQUITY - John G. Baresky

Two medical groups largely focused in urology and associated patient care have joined together with the support of private equity and formed what is likely the largest urology patient care healthcare provider organizations in the United States.

Steward Health Care: Largest Physician-Owned Health System In The Nation - John G. Baresky

Steward Health Care Undergoes Transformation To A Physician-Owned Health System Business Model After Transitioning From Private Equity

Walgreens and VillageMD Launch $1 Billion Strategic Partnership - John G. Baresky

VillageMD and Walgreens Boots Alliance Join Forces In A Robust Primary Care And Pharmacy Services Partnership

RURAL HOSPITALS NEED A CURE FAST - John G. Baresky

Access to care in rural areas is a national healthcare issue that cannot heal on its own... Between January 2010 and January 2020, 114 rural hospitals closed. More than 30 of these were critical access facilities. The University of North Carolina Cecil G. Sheps Center for Research provides further insights as to the total number of rural hospitals closed since 2005 total 170.

National Leader In Fertility Partners With Private Equity - John G. Baresky

One of the largest fertility medical practice organizations in the United States, Shady Grove Fertility, has partnered with the healthcare private equity firm Amulet Capital Partners LP to develop and launch a business solutions platform to support the advanced and unique needs of fertility practices.

Pancreatic Cancer Center of Excellence: Rush University Medical Center - John G. Baresky

Rush University Medical Center Designated As Pancreatic Cancer Center of Excellence

Impact of COVID-19 Creates Healthcare Opportunities for Private Equity: Medical Groups And Large...

Physician practices and medical groups of all sizes are bearing the growing burden of clinical, administrative, financial and technical risk to continue to operate. What kind of opportunity emerges for private equity interests in this challenging environment?

Improving Oncology Access To Care: Community Healthcare Systems - John G. Baresky

St. Catherine Hospital, East Chicago, Indiana is starting the new decade with a new oncology treatment center; a prime example of how to improve access to care

FDA Approves Johns Hopkins University COVID-19 Blood Plasma Therapy Clinical Trial - John G. Baresky

Johns Hopkins University is leading a unique, FDA-approved clinical trial to explore the effectiveness of blood plasma therapy in treating COVID-19 patients.

DuPage Medical Group: $60 Million Expansion - John G. Baresky

Fueled by healthcare private equity, two projects valued at $30 million each reflect national trends as medical practice group business models change

4 Chicago Hospitals Forming New Health System - John G. Baresky

To maintain healthy populations, community residents need access to quality care. Four Chicago hospitals located in the city's southside area are forming a health system to improve care and generate economic opportunity.

Illinois Bone & Joint Institute and Hinsdale Orthopaedics Join Forces - John G. Baresky

A prominent Chicago area orthopedic medical group has recently grown substantially larger. Illinois Bone & Joint Institute (IBJI) has announced another leading orthopedic medical group, Hinsdale Orthopaedics, is joining its group. The combined organizations will have over 25 locations including 4 with MRI centers plus approximately 150 physicians providing an array of advanced orthopedic patient care.

Select Rehabilitation Is Acquiring Kindred Healthcare's RehabCare - John G. Baresky

Select Rehabilitation, a leader in senior care and other specialized patient care services, is buying Kindred Healthcare's RehabCare business unit.

NorthShore University HealthSystem Completes Purchase of Swedish Hospital - John G. Baresky

NorthShore University HealthSystems adds the 5th hospital to its organization with the acquisition of Swedish Hospital in Chicago

Illinois Bone and Joint Institute Adds 3 Orthopedic Surgeons To Staff - John G. Baresky

There is a shortage of physicians across the United States but Illinois Bone and Joint Institute, based in the Chicago suburb of Des Plaines, Illinois has no issues with attracting top surgical talent in one of the largest and most competitive healthcare marketplaces in the nation.

Eruption: Another Mega Health System Merger In The Chicago Marketplace - John G. Baresky

According to Kaufman Hall, a Skokie, Illinois based management consulting firm with a long-established healthcare business practice, the number of hospital mergers and acquisitions in 2017 is on track to exceed the number of deals reported in 2016... Chicago's health system environment undergoing more drastic change...

Tenet Healthcare Selling Off Hospitals...And Maybe More... - John G. Baresky

A survey from Deloitte and the Healthcare Finance Management Association of 90 hospital financial executives from merged or acquired organizations and phone interviews with 13 healthcare leaders indicates hospitals and health systems are looking to mergers and acquisitions for financial, operational, and strategic value... Consolidation, Mergers, Acquisitions...

Steward Health Care: A New Contender - John G. Baresky

Largest Private For-Profit Health System In The United States... ​At the close of September, 2017, Steward Health Care announced it had completed another hospital / health system acquisition and this one has particular significance. Its buyout of IASIS Healthcare now makes it the largest private for-profit health system in the United States.

Non-Profit Health System Mega Merger Underway - John G. Baresky

Ascension And Providence St. Joseph Health forming mega-merger... In mid-December, 2017; two major hospital systems were in merger discussions which would create a new leader in U.S. hospital ownership totaling 191 hospitals. Non-profit Ascension, based in St. Louis, Missouri and non-profit Providence St.

Google Health Unveils Derm Assist Consumer Healthcare Prototype - John G. Baresky

Derm Assist by Google Health is a new dermatology app being developed for consumers

Highmark Health Partners With Verily, A Business Unit of Alphabet-Google - John G. Baresky

Highmark Health Blue Cross Blue Shield hires Verily Life Sciences for Living Health Platform Development

Google Launches Sleep Monitoring Technology - John G. Baresky

Google Health, a business unit of Alphabet (NASDAQ: GOOGL), introduces the new Nest Hub with its innovative Sleep Sensing program

Verily Life Sciences Makes Two Strategic Executive Leadership Hires - John G. Baresky

Verily hires a new chief information officer and a new chief marketing officer

Google Cloud Unveils New Healthcare Interoperability Initiative - John G. Baresky

Google Cloud's new initiative reflects its competitive focus in the healthcare sector

Verily Life Sciences Gains $700 Million From Investor Funding - John G. Baresky

Verily Life Sciences' finances are recharged for 2021. As an independent subsidiary of Alphabet Verily has a unique ability to seek outside and internal sources of cash to invest in its business. Based on this arrangement it recently launched a round of funding that netted it $700 million from its parent company and other investors

Verily Launches Health Insurance Venture Backed By Swiss Re - John G. Baresky

Verily Introduces A Novel Strategy As It Enters The Health Insurance Industry

Verily Life Sciences Study Watch Issued New FDA 510(k) Designation - John G. Baresky

Verily Life Sciences announces Study Watch gets FDA-nod for irregular pulse monitoring with 510(k) designation

Google Dataset Search: A Healthcare Industry Windfall - John G. Baresky

Google has pleasantly surprised us early in 2020 with an incredibly useful resource which will be greatly appreciated by users of healthcare data. Just recently Google announced Google Dataset Search has officially graduated from beta for users to explore and benefit from!

Verily Life Sciences / Alphabet Partnering With Two Healthcare Systems - John G. Baresky

Alphabet ( NASAQ: GOOGL ) announced its Verily Life Sciences business unit is collaborating with California Veterans Affairs VA Palo Alto Healthcare System and Atrius Health, a nonprofit health-care organization based in Auburndale, Massachusetts. Each initiative is centered on data-driven Population Health initiatives.

Alphabet / Google Announce Strategic Leadership Hire: Dr. Karen D. DeSalvo, Chief Health Officer...

Alphabet / Google on healthcare mission Dr. Karen B. DeSalvo, currently a professor at the Dell Medical School, University of Texas in Austin, will be the first person to have the title of Chief Health Officer for Alphabet / Google.

Alphabet Hires Duke University Medical Professor, Former FDA Commissioner For Healthcare...

Alphabet is fortifying its healthcare and technology ranks with an experienced medical, academic and regulatory leader to oversee strategy for two of the company's health divisions: Google Health Verily Life Sciences Introducing Dr. Robert F. Califf The Forge health data science center at Duke University communicated the news about Dr. Califf via its blog.

5 Reasons Fitbit Is A Good Fit For Alphabet — And Some Precautions - John G. Baresky

What may Alphabet potentially gain or lose by acquiring Fitbit? It has been reported Google parent company Alphabet ( NASDAQ: GOOGL ) is seeking to acquire wearable activity tracker Fitbit. Read about the gains, precautions and goals then make your own assessment...

Google A Thinking Force In Healthcare - John G. Baresky

Google's analytic, deep thinking attributes make it ideally suited for the clinical, financial and technical challenges of the healthcare industry. The variety of Google’s deployment in healthcare demonstrates they are willing to invest in learning more about it, greatly improve something that already exists or develop something entirely new and better — which will be unsettling to competitors that have not been innovative.

Google Makes An Investment In Mobile Healthcare Strategy - John G. Baresky

Google is building its healthcare technology presence... Early in August, 2017, Google acquired Senosis Health; a highly specialized app / smartphone technology company which focuses on healthcare-related uses. Financial terms of the buy are presently not known.

Google Joins Forces With The Healthcare Industry In The Battle Against Breast Cancer - John G.

Google On The Move In Oncology... Google is deploying its artificial intelligence capabilities and data analytic resources in the fight against breast cancer. Through using the artificial intelligence ( AI ) concept known as "Deep Learning", Google has been applying its super powers to diagnose cancer cells. Google, Healthcare Academics, Artificial Intelligence, Research...

GlaxoSmithKline Divesting Consumer Products Business Unit - John G. Baresky

Another global healthcare enterprise opts for the spinoff strategy to generate cash and streamline operations

Private Equity Firms Acquire Medline Industries For $34 Billion - John G. Baresky

Private equity investment firms join forces to acquire Medline Industries for $34 billion

Organon Completes Acquisition of Alydia Health - John G. Baresky

Organon (NYSE: OGN) has completed its acquisition of Alydia Health and its Jada System postpartum hemorrhage (PPH) Women's Healthcare device

Becton Dickinson Spinning Off Diabetes Care Business - John G. Baresky

Becton Dickinson forming a new company by divesting its diabetes care business unit

Walmart Escalates Telehealth Services With MeMD Acquisition - John G. Baresky

Walmart (NYSE: WMT) has disclosed it is acquiring telehealth innovator MeMD. Founded in 2010, MeMD is a recognized leader in telehealth services nationwide. MeMD is headquartered in Phoenix, Arizona.

$20.9 Billion: Thermo Fisher Scientific Buys PPD - John G. Baresky

Thermo Fisher Scientific resets contract research organization sector with PPD acquisition

New Telehealth Merger: Grand Rounds and Doctor On Demand - John G. Baresky

Grand Rounds and Doctor On Demand team up to stay on top of global telehealth expansion

Microsoft Acquires Healthcare Innovator Nuance Communications: $19.7 Billion Deal - John G. Baresky

Microsoft and Nuance join forces in $19.7 billion deal to expand healthcare enterprise

Cigna Acquires Telehealth Leader MDLive - John G. Baresky

Telehealth frontrunner MDLive bought by Cigna health services subsidiary Evernorth

$1.85 Billion: Merck Acquires Pandion Therapeutics To Expand Autoimmune Research - John G. Baresky

Merck accelerates its advanced autoimmune therapy development strategy

$3.05 Billion: Horizon Therapeutics Buys Viela Bio - John G. Baresky

Horizon Therapeutics escalates growth as a leader in advanced rare disease therapies with the buyout of Viela Bio

Thermo Fisher Scientific Unveils 2 Strategic Acquisitions Valued At $1.4 Billion - John G. Baresky

Thermo Fisher Scientific kicks off 2021 with 2 deals in less than a week

$6.5 Billion: Walgreens And AmerisourceBergen Deal - John G. Baresky

Walgreens Boots Alliance (NASDAQ: WBA) is selling a majority stake of Alliance Healthcare to AmerisourceBergen for $6.275 billion in cash and two million shares of AmerisourceBergen common stock.

Centene Acquires Magellan Health For $2.2 Billion - John G. Baresky

Centene starts 2021 with a $2.2 billion deal to buy Magellan Health

$880 Million: Eli Lilly Acquires Prevail Therapeutics - John G. Baresky

3rd acquisition by Eli Lilly in 2020; Prevail Therapeutics deal accelerates its progress to expand pipeline and market sector presence

Merck Acquires OncoImmune For $425 Million - John G. Baresky

2020 continues to be a year of clinical and commercial innovation and transformation at Merck with its acquisition of OncoImmune

Novo Nordisk Acquiring Emisphere Technologies For $1.8 Billion - John G. Baresky

Novo Nordisk covets the oral drug formulation capabilities of Emipshere Technologies

Merck Announces $2.75 Billion Acquisition of VelosBio - John G. Baresky

Merck (NYSE: MRK) has announced it is acquiring the oncology research company VelosBio Inc. from Pappas Capital plus other investor stakeholders for about $2.75 billion. VelosBio is based in San Diego, California and was founded in 2017.

$4 Billion: Bayer Acquires Askepios BioPharmaceutical - John G. Baresky

Bayer builds up its gene therapy enterprise with $4 billion Ask Bio acquisition

Bristol-Myers Squibb Acquires MyoKardia for $13 Billion - John G. Baresky

Bristol-Myers Squibb expanding cardiovascular product line with $13 billion MyoKardia acquisition

UnitedHealth Group Acquires Online Pharmacy divvyDOSE - John G. Baresky

UHC (NYSE: UNH) is expanding its pharmacy benefit management services with its acquisition of divvyDOSE. divvyDOSE, founded in 2015, is based in Moline, Illinois.

Johnson & Johnson Acquires Momenta Pharmaceutical For $6.5 Billion - John G. Baresky

Momenta acquisition fuels Johnson & Johnson's expansion in autoimmune therapy

Molina Healthcare Acquires Affinity Health Plan - John G. Baresky

Molina Healthcare acquires Affinity Health Plan of New York

Merck Announces Major Spinoff - John G. Baresky

Merck announces major spinoff to form a new, publicly-traded company by 2021. Merck generates over $42 billion in annual sales and is one of the world's largest pharmaceutical companies.

AbbVie Completes Acquisition of Allergan - John G. Baresky

AbbVie Annual Sales Expected To Surpass $50 Billion In 2020 AbbVie (NYSE: ABBV) has announced that it has received final clearance from regulators and has completed its $63 billion acquisition of Allergan (NYSE: AGN). Based in North Chicago, Illinois, AbbVie is a global healthcare leader that generated over $33.5 billion in 2019 annual sales. Based in Dublin, Ireland with a U.S. headquarters in Irvine, California, Allergan produced over $16 billion in annual sales during 2019.

Molina Healthcare Acquires Magellan Complete Care: $820 Million - John G. Baresky

Molina Healthcare Expands Medicaid and Medicare Business with Magellan Complete Care acquisition

THERMO FISHER SCIENTIFIC HOOKS QIAGEN IN $11.5 BILLION DEAL - John G. Baresky

Thermo Fisher Scientific advances further into genetic testing... Thermo Fisher Scientific (TFS) moves deeper into the genetic testing market sector with its purchase of Qiagen. Qiagen (NYSE: QGEN) specializes in sample and assay technologies used in academic and pharmaceutical research, applied testing, molecular diagnostics, oncology plus other clinical and scientific applications.

Teladoc Acquires Livongo For $18.5 Billion - John G. Baresky

With a market cap of $38 billion, the combination of Teladoc and Livongo are formidable telehealth enterprise

AmerisourceBergen Shuts Down PharMEDium - John G. Baresky

AmerisourceBergen acquired compounding pharmacy PharMEDium for about $2.6 billion in 2015; it is now closing the business unit due to higher operating costs, regulatory standards, quality requirements

ALEXION ACQUIRES PORTOLA PHARMACEUTICALS FOR $1.4 BILLION - John G. Baresky

Alexion Pharmaceuticals (NASDAQ: ALXN) has announced it is acquiring Portola Pharmaceuticals (NASDAQ: PTLA) for $1.41 billion in cash. Founded in 2003, Portola is based in South San Francisco and produces about $116 million in annual sales.

UnitedHealth Group Enters TeleHealth Market With Vivify Acquisition - John G. Baresky

Telehealth continues to build momentum in the United States and the nation's largest commercial payer UnitedHealth Group's ( United Healthcare, Optum ) acquisition of Vivify Health exemplifies this trend.

Merck Sells The StayWell Company To WebMD/Internet Brands - John G. Baresky

Merck Sells The StayWell Company to WebMD/Internet Brands, a KKR private equity holding

INCLISIRAN: Novartis Acquires The Medicines Company For $9.7 Billion - John G. Baresky

Coveting global market potential of LDL agent "Inclisiran" Novartis announces it is acquiring The Medicines Company for $9.7 billion

$3 Billion Deal: Audentes Therapeutics Acquired By Astellas - John G. Baresky

Audentes Therapeutics acquired by Astellas in $3 billion deal; Astellas fully commits to gene therapy

Stryker Corporation Buying Wright Medical For $4 Billion - John G. Baresky

Stryker Corporation ( NYSE: SYK ) is acquiring medical product manufacturer Wright Medical for $4 billion. Wright Medical ( NASDAQ: WMGI ) was started in 1950; it manufactures an array of products aligned with orthopedics including fixation and fusion systems designed for ankles, elbows, shoulders, toes and wrists.

RITE AID ACQUIRES BARTELL DRUGS - John G. Baresky

In an unexpected move, Rite Aid (NYSE: RAD) has announced it is acquiring the privately-held, family-owned and operated Bartell Drugs retail pharmacy chain for $95 million.

Sanofi: Shopping $30 Billion Consumer Healthcare Products Unit - John G. Baresky

Global healthcare leader Sanofi S.A. ( NASDAQ: SNY ) is reportedly weighing options to make significant changes to its commercial organization by spinning off its consumer healthcare products unit or aligning it with a joint-venture partner to reduce $28 billion debt load

3 Multi-Billion Pharma Deals Under Regulatory Scrutiny - John G. Baresky

Pharmaceutical and biotech companies are under heavy pressure to perfomr commercially for investors and clinically by healthcare customers. As they seek to build profitability and their pipelines, mergers and acquisitions are part of their corporate strategies.

Walgreens Considering Going Private; May Someone Else Buy Them First? - John G. Baresky

Could Walgreens be strategically signaling it is up for sale to the highest bidder by presumably going through the motions of taking itself off the market through a private equity deal? Reportedly Walgreens ( NASDAQ: WBA ) is exploring options to take itself private.

UCB Acquires RA Pharma - John G. Baresky

UCB announces deal to buy Ra Pharma for $2.1 billion to expand rare disease pipeline

CVS Health Proposes To Acquire Aetna: Eight Fast Facts - John G. Baresky

The healthcare industry continues to evolve; business models within the sector are changing and propelled by large scale merger and acquisition initiatives... The proposed CVS Health / Aetna deal combines two healthcare industry leaders with wide and deep reach across commercial and consumer business sectors nationwide.

PharMerica + KKR + Walgreens Boots Alliance = $$$$$$$ -John G. Baresky

Under The Radar Of Most Healthcare Executives... On Wednesday, 8/2/2017, PharMerica was acquired by private equity firm KKR (Kohlberg Kravis Roberts). KKR paid $1.4 billion for PharMerica. Headquartered in Louisville, Kentucky, PharMerica is a leader in pharmacy services for assisted living facilities (ALF), hospitals, long term care facilities (LTC), skilled nursing facilities (SNF) and other specialty pharmacy service sectors.

$6.3 Billion: Pharmaceutical Manufacturer STADA Disappears Behind The Curtain Of Private Equity ...

Bain Capital and Cinven... Private equity (PE) continues to be a force in changing the face of the global healthcare industry. STADA, a prominent generic drug manufacturer based in Germany, was taken private last week (8/18/2017) in a $6.3 billion dollar deal. Bain Capital and Cinven were the buyers.

The Horsepower & Strategy Behind Healthcare Product Manufacturer Mergers And Acquisitions - John G.

Johnson & Johnson's $30 billion takeover of Swiss pharma firm Actelion...Gilead's $12 billion acquisition of Kite Pharma...Abbott finalizes Alere deal for $5.3 billion...Reckitt Benckiser Group acquires Mead Johnson Nutrition for $17.9 billion...Cardinal Health acquires Medtronic business unit for $6.1 billion...Teleflex buys Vascular Solutions for $1 billion...Hologic acquires Cynosure for $1.7 billion...Stryker purchases Novadaq for $700 million...Integra Lifesciences buys J&J's Codman...

UHC & SCA: A Super Surgical Team

A 2.3 Billion Dollar Acquisition Has Nationwide Impact: United Healthcare's purchase of Surgical Care Affiliates is re-writing the healthcare industry's playbook.

Improve Hospital and Health System Purchasing and Inventory Management with Digitization...

Healthcare purchasing and inventory management are complex processes that impact the patient care and financial performance of hospitals and health systems, digitization technology can maximize their performance

Optimizing Population Health Data Performance

Medical professionals and risk management executives rely on accurate data to develop, launch and manage effective population health programs for patients

Hospital and Health System Revenue Cycle Management Data Solutions

Healthcare revenue cycle management follows a complex process that need a high level of production, accuracy and control

Digitizing Data Security and HIPAA/PHI Privacy Compliance In Hospitals and Health Systems

Ongoing threats to healthcare data security and HIPPA/PHI privacy require digitally automated measures to assure compliance and protection

Health System EHR Challenge: 5 Million Patient Records

A health system with over 30 hospitals economically and accurately completes its new EHR implementation by digitally fortifying it with 5 million patient records

Enhancing Surgical Preference Card Data In Hospitals, Health Systems, Surgery Centers

A health system improves support for its surgical teams and improving patient care through prioritizing surgical card preference card data in their new EHR system

Hospitals and Health Systems Accelerate EHR System and IT Integration Following Mergers and...

Hospitals and health systems deploy a variety of strategies to reduce cost and improve data resource performance following mergers and acquisitions

Hospital EHR Data Enrichment: Clinical Documents

An enterprising health system fully enhanced their new EHR system by fortifying it with complete patient clinical documentation files to better support medical staff and improve patient care

Hospital EHR Enhancements: Problem List Data

A future-focused healthcare system strategically accounts for Problem List data in their new EHR system

Healthcare Revenue Cycle Management Payer Reimbursement Data Optimizations

A major urban health system deploys 3 strategies to optimize their payer reimbursement data management processes to improve productivity and accuracy while reducing costs

Building Effective Teams For New EHR Implementations

Assembling the right team of administrative, medical, technical and training staff to orchestrate your new EHR implementation is a pivotal exercise

Patient Safety: Medication & Pharmacy Data Migration Success

A hospital successfully integrates it medication and pharmacy data to improve patient safety and reduce data burden on medical and administrative staff

Hospitals and Medical Groups Eliminate Hidden Costs of Old EHR/EMR Systems

Health systems, hospitals and medical groups are reducing costs and data burden by replacing old and under-performing EHR/EMR systems

A New and Robust EHR System: Optimizing Emergency Department Data

A growing health system with 150 hospitals prioritized its Emergency Department EHR data for optimization to improve patient care, reduce costs and eliminate data burden on medical professionals and administrative staff

Improve Hospital And Health System Finance: Digitize Revenue Cycle Management

Hospitals and health systems are improving profitability and productivity through digitizing revenue cycle management

Health System Pricing And Materials Management Data Workflow Optimization

A 15-hospital health system boosts profitably and productivity through optimizing its pricing and materials management data workflows

Reducing Hospital Laboratory and Pathology Data Burden

A leading health system optimizes laboratory and pathology data workflow

Hospital and Health Systems: Reducing Managed Care Payer Claim Denials

Reducing payer claim denials streamlines reimbursement and optimizes hospital and health system finances

Boston Software Systems: The High Performance Standard Of Healthcare RPA

Base presentation content

Hospira Worldwide Oncology Products For Specialty Pharmacy, Clinics And Health Systems

Oncology Injectables, Infusion Technology, Disposables

Hospira Worldwide Surgical Products For Hospitals And Surgical Centers

Anesthesia, Pain Management And Antibiotic Injectables; Infusion Technology, Disposables

Hospira Worldwide Products For Home Infusion

Home Infusion Injectable Therapies, Infusion Technology, Disposables

MORPHINE 2 mg / 4 mg iSECURE PRODUCT LAUNCH

MORPHINE Addition To iSecure Portfolio (HYDROMORPHONE, KETOROLAC, MIDAZOLAM, ONDANSETRON)

FENTANYL PRODUCT PORTFOLIO: AMPULE, SYRINGE, VIAL

FENTANYL Available In 3 Formats And 5 Strengths: 100 mcg, 250 mcg, 500 mcg, 1,000 mcg, 2,500 mcg

SUCCINYLCHOLINE - QUELICIN 20 mg / ml

SUCCINYLCHOLINE QUELICIN NEUROMUSCULAR BLOCKER 200 mg VIAL

LUPRON DEPOT-GYN injection - 3.75 mg / 11.25 mg

LUPRON DEPOT-GYN injection For Women's Healthcare / Endometriosis HEOR Milliman Actuarial Payer Analysis

LUPRON DEPOT- GYN injection - 3.75 mg / 11.25 mg

LUPRON DEPOT-GYN injection For Women's Healthcare / Endometriosis - Hospitals, Health Systems, Government, Employers, MCOs, PBMs,

TAP SourceLupron - ONCOLOGY, GYNECOLOGY, ENDOCRINOLOGY

Product access and reimbursement support for health systems and medical practices; TAP Pharmacy Solutions Partnership with CVS / Caremark and Express Scripts

Anthem Blue Cross Blue Shield Formulary Announcement Preferred Prescribing Status

Prevacid Capsule, Prevacid SoluTab, Prevacid Suspension Formulations

LUPRON DEPOT-PED injection - 7.5 mg / 11.25 mg / 15 mg / 30 mg

LUPRON DEPOT-PED injection for Central Precocious Puberty / CPP

LUPRON DEPOT-URO 7.5 mg / 22.5 mg / 30 mg injection

Lupron Depot-URO injection for Palliative Treatment Of Advanced Prostate Cancer

WALGREENS HEALTH INITIATIVES Medication Management

Clinical Prior Authorization, Step Care, Plan Prior Authorization Prescription Benefit Plan Services

WALGREENS HEALTH INITIATIVES Advantage90

Pharmacy Benefit Management Prescription Benefit Patient Program

WALGREENS HEALTH INITIATIVES MedMonitor

Retrospective Medical And Pharmacy Care Data Analytics Clinical Program

A Conversation About Medicare And Healthcare Reform - John G. Baresky

How will healthcare reform impact Medicare?

A Conversation About Medicare Part A, B, C and D - John G. Baresky

A discussion covering the basics of Medicare

A Conversation About Drug Coverage And Healthcare Reform - John G. Baresky

A discussion about prescription drug coverage and healthcare reform

MUCK RACK: The Global Forum Of Verified Journalists And Writers

A selection of Bare Sky Marketing healthcare content writing examples plus professional biography, candid responses to Muck Rack's interview questions, Bare Sky Marketing Twitter posts, links to Bare Sky Marketing resources

MEDIUM: Where Readers Find Dynamic Thinking And Where Expert Voices Share Their Writing

CONTENTLY: The World’s Best Vetted Journalists, Designers, Videographers, Editors And Illustrators

Select Bare Sky Marketing Healthcare Content Writing Examples And Healthcare Marketing Resources

BARE SKY MARKETING HEALTHCARE CONTENT MARKETING WRITING

Authentic, fact-based healthcare content writing services for medical, business, investor, payer, academic, patient and consumer audiences

HEALTHCARE MEDICAL PHARMACEUTICAL DIRECTORY.COM

Marketing strategy for pharmaceutical, medical device & technology, patient care, clinical service, medical software and other healthcare enterprises

HEALTHCARE MEDICAL PHARMACEUTICAL DIRECTORY.COM

Healthcare industry insights on events, trends and innovation